Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AstraZeneca

AstraZeneca boss uncertain if yearly Covid-19 boosters for healthy are good use of resources

The chief executive officer believes most of the vaccinated population now has a "foundation immunity against severe disease"

Wales Online

AstraZeneca boss unsure if annual Covid-19 boosters are good use of resources

Chief executive officer Pascal Soriot said he believes most of the vaccinated population has a ‘foundation immunity against severe disease’.

The Independent UK

New Covid drug could protect 500,000 vulnerable Brits but Government refuses to fund it

Brave schoolboy Max Johnson said the Government should offer vital protection to hundreds of thousands of immuno-compromised people who, like him, could risk being killed by Covid-19

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

FTSE 100 chief executive average pay jumps by 39% to £3.4m

“To see CEO pay rocketing to more than 100 times the average salary is sickening,” say union bosses

The Independent UK

Princess Diana's bodyguard seen for first time in 5 years after surviving Paris car crash

Trevor Rees-Jones, Princess Diana’s former bodyguard and now head of security for AstraZeneca, was photographed outside a Morrisons store in Shropshire 25 years on from the fatal car crash

Daily Mirror

Morrison government failed to provide priority for at-risk groups in vaccine rollout, report says

National audit report on vaccine rollout found planning ‘was not timely’ and distribution to priority populations had not ‘met targets’

The Guardian - AU

No plans for UK to order more supplies of AstraZeneca Covid vaccine

JCVI says mRNA vaccines such as the Pfizer and Moderna jabs are the most effective for UK booster programme

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

How science is getting closer to a world without animal testing

New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice

Financial Times

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Benzinga

More than a half billion doses of COVID vaccine made in Baltimore dumped, congressional panel finds

BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response.

Tribune News Service

Zed admits 'deep sense of dread' before election loss

In his first media interview since losing his Senate seat, Zed Seselja said he believed voters had made up their minds about the Morrison government before the election.

The Canberra Times

Climate change puts Lyme disease in focus for France's Valneva after COVID blow

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

Reuters

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

AstraZeneca raises sales guidance on demand for Covid treatment

The Anglo-Swedish pharmaceutical giant said it expects the Evusheld Covid-19 injection to help drive sales of at least 20% for the year.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

AstraZeneca claims to have saved six million lives with COVID vaccine

Group profit in the first half of the year spiked by 48% as Michel Demaré lined up for chair

The Guardian - UK

Covid vaccine figures lay bare global inequality as global target missed

Only one in seven people in low-income countries are fully vaccinated with poorest pushed to the ‘back of the queue’

Benzinga

This Is What Whales Are Betting On AstraZeneca

Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

Jabs 'saved half a million people'

A research team from Mahidol University has estimated that the government's Covid-19 vaccination campaign over the past two years prevented nearly 490,000 deaths.

Wales Online

Cancer drug found to regenerate a damaged spine

AZD1390 is under investigation by AstraZeneca, who helped develop a Covid-19 vaccine that has seen more than two billion doses released worldwide

The Hindu

Bhutan-China ties won’t harm India’s interests: Bhutan Foreign Minister

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program

Here's a roundup of top developments in the biotech space over the last 24 hours:

360info

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

The Independent UK

1.1 billion Covid vaccine doses wasted globally, estimates suggest

‘A lot of Covid-19 vaccine wastage has been driven by the deeply unequal global response to this pandemic,’ says global health campaigner

The Conversation

COVID vaccines and pregnancy: a review of the evidence shows they are safe

COVID vaccines have been contentious ever since they were developed in response to the coronavirus pandemic, though the evidence is that they are safe and effective. One of the concerns has been whether the vaccines were safe for pregnant women. A recent review looked at the evidence available from North…

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.